Grantham, Mayo, Van Otterloo & Co (GMO)’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-1,114,409
Closed -$50.6M 816
2020
Q2
$50.6M Sell
1,114,409
-31,785
-3% -$1.42M 0.38% 53
2020
Q1
$50.6M Buy
+1,146,194
New +$44.8M 0.42% 52

Other funds holding QGEN

Grantham, Mayo, Van Otterloo & Co (GMO)'s QGEN Position: Q3 2020 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Qiagen (QGEN) in Q3 2020, closing a stake of 1,114,409 shares — an estimated $50.6M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in QGEN in Q1 2020 and held it in 2 quarters. The position peaked at $50.6M in Q2 2020. 252 funds tracked by Wall St. Rank hold QGEN as of Q3 2020.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Qiagen position as of Q3 2020 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 1,114,409 Qiagen shares in Q3 2020, an estimated $50.6M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Qiagen in Q1 2020 and held it in 2 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Qiagen position peaked at $50.6M in Q2 2020.
  • 252 funds tracked by Wall St. Rank held Qiagen as of Q3 2020.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2020, filed 13 Nov 2020.